Transcripts Orexo AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 16:19:40 07/05/2024 BST			5-day change	1st Jan Change
19.2 ^SEK	-1.34%		+13.61%	+24.19%

04-17	Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment	MT
04-17	Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US	CI

Transcript : Orexo AB, 2023 Earnings Call, Feb 08, 2024	02-08
Transcript : Orexo AB, Q3 2023 Earnings Call, Nov 02, 2023	11-02
Transcript : Orexo AB, Q2 2023 Earnings Call, Jul 18, 2023	18/07/23
Transcript : Orexo AB, Q1 2023 Earnings Call, Apr 27, 2023	27/04/23
Transcript : Orexo AB, 2022 Earnings Call, Jan 26, 2023	26/01/23
Transcript : Orexo AB, Q3 2022 Earnings Call, Nov 03, 2022	03/11/22
Transcript : Orexo AB, Q2 2022 Earnings Call, Jul 14, 2022	14/07/22
Transcript : Orexo AB, Q1 2022 Earnings Call, Apr 28, 2022	28/04/22
Transcript : Orexo AB, Q4 2021 Earnings Call, Jan 27, 2022	27/01/22
Transcript : Orexo AB, Q3 2021 Earnings Call, Nov 03, 2021	03/11/21
Transcript : Orexo AB, Q2 2021 Earnings Call, Jul 15, 2021	15/07/21
Transcript : Orexo AB, Q1 2021 Earnings Call, Apr 29, 2021	29/04/21
Transcript : Orexo AB, Q4 2020 Earnings Call, Jan 28, 2021	28/01/21
Transcript : Orexo AB, Nine Months 2020 Earnings Call, Nov 04, 2020	04/11/20
Orexo AB Provides Earnings Guidance for the Fourth Quarter and Full Year of 2020	04/11/20	CI
Transcript : Orexo AB - Special Call	01/10/20
Transcript : Orexo AB, Q2 2020 Earnings Call, Jul 16, 2020	16/07/20
Transcript : Orexo AB - Special Call	02/07/20
Transcript : Orexo AB, Q1 2020 Earnings Call, Apr 28, 2020	28/04/20
Orexo AB Provides Earnings Guidance for the Year 2020	28/04/20	CI

No results for this search